Dolby Laboratories, Inc. — Q3 FY2014 Form 10-Q
Business context and reporting period: Dolby develops and licenses audio, video and voice technologies and also sells cinema, broadcast and related products and services. The fiscal quarter ended June 27, 2014; year-to-date figures cover 39 weeks. Unless noted, amounts are USD millions. Comparisons are with the corresponding 2013 periods.
Financial performance and position
| Metric | Q3 FY2014 | Q3 FY2013 | 39 weeks FY2014 | 39 weeks FY2013 |
|---|---|---|---|---|
| Revenue | $223.4 | $207.1 | $733.2 | $693.0 |
| Gross margin | $204.5 (91.6%) | $182.7 (88.2%) | $675.5 (92.1%) | $619.8 (89.4%) |
| Operating income | $50.6 | $36.9 | $215.4 | $188.2 |
| Net income attributable to Dolby | $39.8 | $30.2 | $160.2 | $143.5 |
| Diluted EPS | $0.38 | $0.29 | $1.55 | $1.39 |
| Operating cash flow | Not separately provided | Not separately provided | $272.0 | $209.4 |
- Quarter revenue increased 7.9% year over year; licensing revenue rose 11% to $205.6 million and represented 92% of revenue. Products revenue fell 25% to $13.0 million; services revenue declined 5% to $4.8 million.
- Quarter operating income rose 37%; net income attributable to Dolby rose 32%. Higher licensing revenue and improved product gross margin contributed, while research and development, sales and marketing, and general and administrative expenses all increased.
- At June 27, cash and cash equivalents were $590.1 million, short- and long-term investments totaled $495.0 million, and working capital was $801.8 million. Cash, cash equivalents and investments totaled $1.085 billion. The filing reports no debt balance on the balance sheet.
- Total assets were $1.939 billion and total liabilities were $252.6 million. Year-to-date investing cash flow was a use of $111.3 million; financing cash flow was a use of $24.2 million. Cash increased $135.7 million from fiscal year-end.
Material changes versus prior comparable periods
- Licensing benefited from higher television and set-top-box shipments, royalty back payments and settlements, and revenue from new game consoles. PC licensing remained pressured by PC-market declines and the Windows 8 licensing-model transition; management said that transition was largely complete.
- Product revenue continued to decline amid lower digital cinema and 3D equipment shipments and selling prices. Product gross margin improved in the quarter to 16% from 6%, reflecting lower costs and product mix, but year-to-date product gross margin declined to 23% from 21%? The filing reports 23% versus 21%, an increase despite lower dollar gross margin.
- Quarter operating expenses rose 6% to $153.9 million. General and administrative expense increased 15%, including costs related to the pending Doremi acquisition and legal, patent, HR and IT activities.
- Year-to-date net cash from operations increased $62.5 million, primarily due to higher collections and net income. Investing cash flow shifted from a $186.8 million source to a $111.3 million use, largely reflecting investment-security transactions and increased capital and intangible-asset purchases. The prior year included the $408.2 million special dividend; no dividend was paid in the current year-to-date period.
Outlook, commentary, risks and unusual items
- No comprehensive financial forecast or earnings guidance is provided. Management stated that available liquidity and operating cash flows should meet anticipated cash requirements for at least the next 12 months.
- Management expected mobile revenue to decline to approximately 12% of licensing revenue in Q4 FY2014, from 13% in Q3, after Samsung excluded Dolby Digital Plus from its recently released Galaxy smartphones and tablets.
- Dolby agreed to acquire Doremi Labs for $92.5 million cash plus up to $20.0 million in contingent consideration over four years. The deal remained subject to customary conditions and regulatory review; closing was anticipated by the end of calendar 2014. Dolby warned that the announcement could disrupt cinema customer purchases and that completion was not assured.
- Key business risks include dependence on licensees and royalty reporting, rapid technology change, competition and pricing pressure, declining optical-disc and mature digital-cinema markets, mobile adoption, patent expirations and unauthorized use of intellectual property. Dolby also cited foreign-exchange, supplier, cybersecurity and international-compliance risks.
- China’s NDRC and Korea’s KFTC had initiated competition-law reviews and requested information; Dolby said it was cooperating. The company said ordinary-course legal matters were not expected to have a material adverse effect, while noting outcomes can be unpredictable.
- Unusual items included a $3.0 million impairment that reduced a cost-method investment to zero, a $0.4 million gain on a UK property sale, and a $0.7 million restructuring credit in the quarter. The fiscal 2014 restructuring plan had recorded $3.3 million of year-to-date charges, primarily severance.
- About $407.8 million, or 38%, of cash, cash equivalents and investments was held by foreign subsidiaries; repatriation could result in U.S. federal and foreign withholding taxes. Contractual commitments totaled $243.2 million, including $149.0 million for naming rights, largely due after fiscal 2018.
- The Dolby family and affiliates controlled approximately 91.2% of combined voting power at quarter-end through the dual-class share structure. Disclosure controls were assessed as effective, and no material change in internal control was reported.
Important facts for investors to verify
- Whether licensing growth—particularly broadcast, mobile and gaming—can offset PC, optical-disc and cinema-product declines, and the expected Q4 mobile mix reduction.
- Regulatory status, closing conditions, consideration and integration risks for the Doremi acquisition, including any effect on cinema customers.
- Developments and potential financial exposure, if determinable, from the Korean and Chinese competition reviews and other intellectual-property or licensing disputes.
- Cash and investment composition, foreign-subsidiary balances and potential repatriation tax costs; confirm the absence of debt or other financing obligations beyond those disclosed.
- How recurring expenses, restructuring, investment impairment, tax-rate changes and stock repurchases affect future earnings and cash generation.